White House nears deal to lower obesity drug prices for Medicare coverage

The GLP-1 drugs, produced by Novo Nordisk and Eli Lilly, have been credited with helping weight-loss, preventing diabetes and other positive effects.

View original article
Contributor: Dan Diamond, Rachel Roubein